Cargando…

The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma

BACKGROUND: The BAP1 mutation is commonly found kidney renal clear cell carcinoma (KIRC) and a potential biomarker of individualized therapy. We evaluated the clinical significance of BAP1 mutation in the prognosis and treatment therapies for KIRC. Potential key pathways and related genes associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Guobin, Xuan, Zijun, Li, Zhiqin, Huang, Shuitong, Chen, Guangming, Wu, Yonglu, Chen, Xianxi, Liang, Zhijin, Wu, Aiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475666/ https://www.ncbi.nlm.nih.gov/pubmed/32944533 http://dx.doi.org/10.21037/tau-20-1079

Ejemplares similares

The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials
por: Tan, Guobin, et al.
Publicado: (2020)

Risk factors for hemorrhage requiring embolization after percutaneous nephrolithotomy: a meta-analysis
por: Li, Zhiqin, et al.
Publicado: (2020)

Bioinformatics analysis based on immune-autophagy-related lncRNAs combined with immune infiltration in bladder cancer
por: Tan, Guobin, et al.
Publicado: (2021)

EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis
por: Sun, Chenmin, et al.
Publicado: (2018)

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings
por: Feng, Zhan, et al.
Publicado: (2020)

A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
por: Ge, Yu-Zheng, et al.
Publicado: (2017)

Effects of BAP1, Ki-67 index, and Id-1 in patients with clear cell renal carcinoma and their correlation with clinical features and prognosis
por: Yang, Jing, et al.
Publicado: (2020)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

Integrative analysis of TRPV family to prognosis and immune infiltration in renal clear cell carcinoma
por: Gong, Zixuan, et al.
Publicado: (2022)

A review of the relatively complex mechanism of JS-K induced apoptosis in cancer cells
por: Tan, Guobin, et al.
Publicado: (2019)

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
por: Zhou, Quan, et al.
Publicado: (2020)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Sun, Lei, et al.
Publicado: (2022)

Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma
por: Wi, Young Chan, et al.
Publicado: (2018)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()
por: Bihr, Svenja, et al.
Publicado: (2019)

Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
por: Szegedi, Krisztián, et al.
Publicado: (2023)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma
por: Zhang, Minhao, et al.
Publicado: (2023)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics
por: Wu, Hongrong, et al.
Publicado: (2021)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma
por: Cui, Hao, et al.
Publicado: (2020)

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
por: Tang, Gonglin, et al.
Publicado: (2023)

Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Gao, Ruizhi, et al.
Publicado: (2021)

RhierBAPS: An R implementation of the population clustering algorithm hierBAPS
por: Tonkin-Hill, Gerry, et al.
Publicado: (2018)

The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma
por: Bai, Shuheng, et al.
Publicado: (2020)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Ren, Xueting, et al.
Publicado: (2021)

BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
por: Friedhoff, Jana, et al.
Publicado: (2022)

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
por: Wang, Licheng, et al.
Publicado: (2023)

Identification of prognosis‐related alternative splicing events in kidney renal clear cell carcinoma
por: Zuo, Yongdi, et al.
Publicado: (2019)

Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
por: Luo, Gang, et al.
Publicado: (2023)

Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma
por: Jiang, Huiming, et al.
Publicado: (2020)

MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma
por: Huang, Minjiang, et al.
Publicado: (2021)

Novel immune‐related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
por: Zhou, Libin, et al.
Publicado: (2022)

Structural and Biophysical Characterization of the Cytoplasmic Domains of Human BAP29 and BAP31
por: Quistgaard, Esben M., et al.
Publicado: (2013)

APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma
por: Peng, Ting, et al.
Publicado: (2022)

A Five Collagen-Related Gene Signature to Estimate the Prognosis and Immune Microenvironment in Clear Cell Renal Cell Cancer
por: Shi, Xiaokai, et al.
Publicado: (2021)

RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma
por: Li, Diangeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a2d5sr17l0sgvtqe8otjafr903